projet PHYTO CRAMPES
Food supplement declared in France, declaration No 2024-3-1376
projet PHYTO CRAMPES is a food supplement declared in France. Status: retiré du marché le 3 April 2024. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- New Stefal Holding
- Status
- Retiré du marché le 3 April 2024
- Form
- Comprimé
- Daily dose
- 3 comprimés
- Directions for use
- Prendre 3 comprimés par jour idéalement répartis sur la journée avec un grand verre d’eau
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Sous anticoagulants, Sous antidiabétiques, Sous traitement pour la thyroïde
Declaration 140369, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 3 April 2024, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Lithothamnion calcareum (Pallas) Areschoug | Thalle | Poudre (de plantes séchées ou broyées) | 400 mg |
| Cinchona pubescens Vahl | Ecorce | Extrait sec aqueux | 150 mg |
| Panax ginseng C.A.Mey. | Parties aériennes | Extrait sec hydroalcoolique | 90 mg |
| Aesculus hippocastanum L. | Graine | Extrait sec hydroalcoolique | 37.5 mg |
Other active ingredients
| Name | Per day |
|---|---|
| L-leucine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Hydroxyde de magnésium | Magnésium | 250 mg | 300 mg |
| Cyanocobalamine | Vitamine B12 | pas d'effet indésirable défini | dose annulée par le Conseil d'État en 2011 |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
| Cholécalciférol | Vitamine D | 100 µg (4,000 UI) | 5 µg (200 UI) |
Additives
E420, E470b
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Les compléments alimentaires doivent être utilisés dans le cadre d'un mode de vie sain et ne pas être utilisés comme substituts d'un régime alimentaire varié et équilibré. Ne pas dépasser la dose journalière recommandée. Tenir hors de la portée des jeunes enfants. Ne convient pas aux femmes enceintes ou qui allaitent. Contient de l'iode (au maximum 28µg/dose journalière recommandée). Déconseillé aux personnes souffrant de troubles de la thyroïde. Déconseillé chez les personnes sous traitement antidiabétique. Déconseillé chez les personnes sous traitement anticoagulant. Réservé à l'adulte. Une consommation excessive peut avoir des effets laxatifs. A conserver au frais, au sec et à l'abri de la lumière.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Panax ginseng C.A.Mey.
Read the warning, when it applies and the studies cited
PANAX GINSENG
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Vuksan et al. 2008; Seely et al. 2008; Sievenpiper et al. 2006; ESCOP 2003; Tetsutani et al. 2000; Sotaniemi et al. 1995; Chin 1991).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, blood thinners or digoxin (Brinker 2010; Lee et al. 2008a; Dasgupta and Reyes 2005; Janetzki and Morreale 1997; Gonzalez-Seijo et al. 1995; Shader and Greenblatt 1988; Jones and Runikis 1987; Shader and Greenblatt 1985).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency (Bensky et al. 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience insomnia, anxiety or headaches (Lee et al. 2008b; Vuksan et al 2008; de Andrade et al.2007; Sievenpiper et al. 2006; Coon and Ernst 2002; Ellis and Reddy 2002; Scaglione et al. 2001; Siegel 1979).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Aesculus hippocastanum L.
Read the warning, when it applies and the studies cited
Horse Chestnut - Aesculus Hippocastanum
Route of administration: Oral (Bradley 2006; ESCOP 2003)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.